期刊文献+

烧伤细菌感染的噬菌体治疗 被引量:4

Phage therapy for bacterial infection of burn
原文传递
导出
摘要 严重烧伤患者由于体表生理防御屏障受损、全身免疫功能下降、坏死组织广泛存在以及外界或自身菌群侵袭,其感染易感性大大增加。感染是严重烧伤的常见并发症,烧伤脓毒症则是导致烧伤患者MOF和死亡的主要原因。 With the long-term and widespread use of antibiotics, drug resistance of bacteria has become a major problem in the treatment of burn infection. For treating multidrug resistant bacteria, phage therapy has become the focus of attention. Development of phage therapy to fill the blank of this field in China is extremely urgent.
出处 《中华烧伤杂志》 CAS CSCD 北大核心 2016年第9期513-516,共4页 Chinese Journal of Burns
基金 国家自然科学基金(81571896) 全军后勤科研计划重点项目(BWS11J039)
关键词 烧伤 细菌感染 细菌噬菌体 治疗 Burns Bacterial infections Bacteriophages Therapy
  • 相关文献

参考文献27

  • 1ChurchD, ElsayedS, ReidO, et al. Burn wound infections[J]. Clin Microbiol Rev,2006, 19(2): 403-434. DOI:10.1128/CMR.19.2.403-434.2006.
  • 2PolavarapuN, OgilvieMP, PanthakiZJ. Microbiology of burn wound infections[J]. J Craniofac Surg, 2008, 19(4): 899-902.DOI:10.1097/SCS.0b013e318175b4f0.
  • 3HauserAR, MecsasJ, MoirDT. Beyond antibiotics: new therapeutic approaches for bacterial infections[J]. Clin Infect Dis, 2016, 63(1): 89-95.DOI:10.1093/cid/ciw200.
  • 4PelegAY, SeifertH, PatersonDL. Acinetobacter baumannii: emergence of a successful pathogen[J]. Clin Microbiol Rev, 2008, 21(3): 538-582.DOI:10.1128/CMR.00058-07.
  • 5GongYL, ChenJ, LiuCJ, et al. Comparison of pathogens and antibiotic resistance of burn patients in the burn ICU or in the common burn ward[J]. Burns, 2014, 40(3):402-427.DOI:10.1016/j.burns.2013.07.010.
  • 6KaraiskosI, GiamarellouH. Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches[J]. Expert Opin Pharmacother, 2014, 15(10): 1351-1370. DOI:10.1517/14656566.2014.914172.
  • 7SalmondGP, FineranPC. A century of the phage: past, present and future[J]. Nat Rev Microbiol, 2015, 13(12): 777-786.DOI:10.1038/nrmicro3564.
  • 8KutateladzeM, AdamiaR. Bacteriophages as potential new therapeutics to replace or supplement antibiotics[J]. Trends Biotechnol, 2010, 28(12): 591-595.DOI:10.1016/j.tibtech.2010.08.001.
  • 9ChaudhryWN, HaqIU, AndleebS, et al. Characterization of a virulent bacteriophage LK1 specific for Citrobacter freundii isolated from sewage water[J]. J Basic Microbiol, 2014, 54(6): 531-541.DOI:10.1002/jobm.201200710.
  • 10BorysowskiJ, GórskiA. Is phage therapy acceptable in the immunocompromised host?[J]. Int J Infect Dis, 2008, 12(5): 466-471.DOI:10.1016/j.ijid.2008.01.006.

二级参考文献45

  • 1周铁丽,林小玲,冯红军,李超,刘庆中,王赛芳,王邦松.鲍氏不动杆菌对亚胺培南耐药机制研究[J].中华医院感染学杂志,2007,17(4):375-378. 被引量:16
  • 2Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram negative bacilli: need for international harmonization in terminology[J]. Clin Infect Dis, 2008, 46(7): 1121-1122.
  • 3Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twenty fourth informational supplement, 2014, M100-S24.
  • 4Hu F, Chen S, Xu X, et al. Emergence of carbapenem- resistant Enterobacteriaceae clinical isolates from a teaching hospital in Shanghai, China[J]. J Med Microbiol, 2012, 61 (Pt 1): 132-136.
  • 5Van Duin D, Kaye KS, Neuner EA, et al. Carbapenem-resistant Enterol2acteriaceae= a review of treatment and outcomes [J]. Diagn Microbiol Infect Dis, 2013, 75(2): 115-120.
  • 6Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase- producing Klebsiella tmeumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems[J]. Antimicrob Agents Chemother, 2014, 58 (4): 2322-2328.
  • 7Tascini C, Jagliaferri E, Giani T, et al. Synergistic activity of colistin plus rifampin against colistin resistant KPC producing Klebsiella pneumoniae [J]. Antimicrob Agents Chemother, 2013, 57(8): 3990-3993.
  • 8Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions [J]. Clin Microbiol Rev, 2012, 25(4): 682-707.
  • 9PelegAY, SeifertH, PatersonDL. Acinetobacter baumannii: emergence of a successful pathogen[J]. Clin Microbiol Rev, 2008,21(3):538-582. DOI:10.1128/CMR.00058-07.
  • 10DijkshoornL, NemecA, SeifertH. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii[J]. Nat Rev Microbiol, 2007,5(12):939-951.DOI:10.1038/nrmicro1789.

共引文献732

同被引文献82

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部